Cargando…

Statement on the relevance of the groundwater metabolite RH‐2651 in the assessment of confirmatory data on the active substance tebufenozide

In 2018, the risk assessment for tebufenozide in light of confirmatory data requested following approval in accordance with Article 6(1) of Directive 91/414/EEC and Article 6(f) of Regulation (EC) No 1107/2009 concluded that based on the submitted data, the metabolite RH‐2651 has to be considered as...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Statement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596960/ https://www.ncbi.nlm.nih.gov/pubmed/34868370 http://dx.doi.org/10.2903/j.efsa.2021.6920

Ejemplares similares

Statement on the active substance flupyradifurone
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Statement on the active substance acetamiprid
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Statement on the short‐term (acute) dietary risk assessment and evaluation of confirmatory data for certain maximum residue levels (MRLs) for thiacloprid
Publicado: (2023)

Statement of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on the design and conduct of groundwater monitoring studies supporting groundwater exposure assessments of pesticides
por: Hernandez‐Jerez, Antonio, et al.
Publicado: (2023)

Statement concerning the review of the approval of the active substance ipconazole
Publicado: (2022)

Statement concerning the review of the approval of the active substance pirimicarb
Publicado: (2023)

Statement on the impact of the harmonised classification on the conclusion on the peer review of the pesticide risk assessment of the active substance flutianil
Publicado: (2018)

Statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos
Publicado: (2019)

Statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos‐methyl
Publicado: (2019)

Statement concerning the assessment of environmental fate and behaviour and ecotoxicology in the context of the pesticides peer review of the active substance dimoxystrobin
Publicado: (2022)

Updated statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos‐methyl
Publicado: (2019)

Statement concerning the testing strategy and timelines proposed by the applicant for the assessment of the endocrine disruption properties of acibenzolar‐S‐methyl in the context of the review of the approval of the active substance
Publicado: (2023)

Statement of the PPR Panel on a framework for conducting the environmental exposure and risk assessment for transition metals when used as active substances in plant protection products (PPP)
por: Hernandez‐Jerez, Antonio, et al.
Publicado: (2021)

Lack of confirmatory data following Article 12 MRL reviews for 2,4‐d, fenhexamid and iprovalicarb
Publicado: (2021)

Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
Publicado: (2023)

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
por: Turck, Dominique, et al.
Publicado: (2022)

Scientific statement on the coverage of bats by the current pesticide risk assessment for birds and mammals
por: Hernández‐Jerez, Antonio, et al.
Publicado: (2019)

Statement on the revised targeted risk assessment for certain maximum residue levels for nicotine
Publicado: (2023)

Statement on the safety of d‐ribose
por: Turck, Dominique, et al.
Publicado: (2018)

Updated risk assessment concerning the risk to wild mammals for the active substance gamma‐cyhalothrin
Publicado: (2021)

ESR Statement on the Validation of Imaging Biomarkers
Publicado: (2020)

ESR statement on portable ultrasound devices
Publicado: (2019)

Statement on non‐dietary exposure on diquat
Publicado: (2018)

Statement on risk mitigation measures on cypermethrin
Publicado: (2019)

Statement on the dietary risk assessment for the proposed temporary maximum residue level for chlormequat in oyster mushrooms
Publicado: (2019)

Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
por: Naegeli, Hanspeter, et al.
Publicado: (2021)

Statement on the dietary exposure assessment for the temporary maximum residue levels for chlordecone in certain products of animal origin
Publicado: (2020)

ESR statement on the stepwise development of imaging biomarkers
Publicado: (2013)

ESR statement on good scientific practice and publishing
Publicado: (2012)

Position Statement on Indications of Echocardiography in Adults - 2019
por: Barberato, Silvio Henrique, et al.
Publicado: (2019)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

ESR statement on new approaches to undergraduate teaching in Radiology
Publicado: (2019)

Scientific statement on the maximum residue levels for potassium phosphonates
Publicado: (2022)

Statement on the BfR opinion regarding the toxicity of 2‐chloroethanol
por: Borroto, Jorge, et al.
Publicado: (2022)

Statement on the translocation potential by Pseudomonas chlororaphis MA342 in plants after seed treatment of cereals and peas and assessment of the risk to humans
por: Hernandez‐Jerez, Antonio F, et al.
Publicado: (2020)

Statement on the short‐term (acute) dietary risk assessment for the temporary maximum residue levels for nicotine in rose hips, teas and capers
Publicado: (2022)

Pesticide risk assessment for the active substance pymetrozine in light of negligible exposure data submitted
Publicado: (2017)

Review of the residue definitions for risk assessment of pyrethroids forming common metabolites
Publicado: (2023)

European Commission guidelines on clinical audit. Statement by the European Society of Radiology
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3h1t5436c3l29d4koo06uosel6